Livsmed Inc (KOSDAQ:491000)

South Korea · Delayed Price · Currency is KRW

72,500

+4,300 (6.30%)

At close: Apr 29, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Medical Device Import/Export and Research and Development	51.19B	27.12B	17.27B	9.68B
Medical Device Import/Export and Research and Development Growth	88.75%	57.07%	78.42%	-
Total	51.19B	27.12B	17.27B	9.68B
Total Growth	88.75%	57.07%	78.42%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
South Korea	45.68B	23.43B	14.19B	8.06B
South Korea Growth	94.97%	65.11%	76.10%	-
USA	3.07B	2.11B	1.69B	705.80M
USA Growth	45.38%	24.76%	139.60%	-
Germany	962.26M	740.63M	507.51M	368.47M
Germany Growth	29.92%	45.93%	37.74%	-
Other	1.48B	839.86M	876.63M	544.47M
Other Growth	76.09%	-4.19%	61.01%	-
Total	51.19B	27.12B	17.27B	9.68B
Total Growth	88.75%	57.07%	78.42%	-

Source: S&P Global Market Intelligence.